2012—2014年辽宁省肿瘤医院抗肿瘤药物的使用情况分析  

Analysis on usage of anticancer drugs in Liaoning Cancer Hospital and Institute from 2012 to 2014

作　　者：黎苏[1] 陈琴[1] 项婧[1] 祁英杰[1] 罗显峰[1] 

机构地区：[1]辽宁省肿瘤医院药学部,辽宁沈阳110042

出　　处：《现代药物与临床》2015年第9期1150-1153,共4页Drugs & Clinic

摘　　要：目的分析辽宁省肿瘤医院抗肿瘤药物的使用情况,为临床合理应用抗肿瘤药物提供参考。方法对2012—2014年辽宁省肿瘤医院抗肿瘤药物的应用种类、剂型、销售金额进行统计分析。结果抗肿瘤药物的销售总金额呈逐年上升趋势,细胞毒类抗肿瘤药物的销售金额一直排名第1位;剂型中注射剂的构成比一直居第1位;多西他赛、吉西他滨、来曲唑的销售金额一直占据前3位。结论临床应选择适合的抗肿瘤药物,提高患者生存率和生活质量,促进抗肿瘤药物的合理应用。Objective To analyze the usage of anticancer drugs in Liaoning Cancer Hospital and Institute, and to provide reference for rational use of anticancer drugs.Methods The applied category, dosage form, and consumption sum of anticancer drugs in Liaoning Cancer Hospital and Institute from 2012 to 2014 were analyzed statistically. Results The consumption sum of the anticancer drugs increased year by year. Consumption sum of cytotoxic drugs ranked the first all the time. The constituent ratio of injections ranked the first all along. Consumption sum of docetaxel, gemcitabine, and letrozole were firmly at the top three. Conclusion Clinicians should select appropriate anticancer drugs, and improve survival and quality of life for patients, and promote the rational use of anticancer drugs.

关 键 词：抗肿瘤药物 用药分析 销售金额 

分 类 号：R979.1[医药卫生—药品]